594 - Could Patent Reform Lower Drug Prices? @JohnsHopkinsSPH
594 - Could Patent Reform Lower Drug Prices?  @JohnsHopkinsSPH
Uploaded March 2023 | Updated September 2026, 6 hours ago
Humira is an immunosuppressive drug used to treat arthritis, plaque psoriasis, Crohn's disease, and ulcerative colitis, is one of the most profitable drugs of all time. In this episode, Tahir Amin, founder and executive director of the Initiative for Medicines, Access & Knowledge., joins Dr. Josh Sharfstein to talk about how gaming the patent system may have helped stave off competition, costing consumers billions of dollars. They also discuss what it would take to reform the system.
594 - Could Patent Reform Lower Drug Prices?605 - World Immunization Week: The Big Catch-Up and Preventing a Large-scale Global Outbreak of...564 - How to Be a Climate Change Advocate: Howard Frumpkin on How Environmental Health = Our...Media Briefing: Dementia and Brain HealthDid you know the Bloomberg School of Public Health houses one of the largest insectaries in the US?610 - Public Health in the Field: How Policy Can Help Solve the Black Maternal Health CrisisThe sun is out and sunscreen is in! ☀️560 - Preventing Child Sexual Abuse581 - The Kids are Not AlrightHelp is available for people thinking about suicide. #shortsThe Importance of Knowing and Optimizing Your Hearing Health...At ANY AgeThis small spray can save a life. #shorts
Johns Hopkins Bloomberg School of Public Health |

594 - Could Patent Reform Lower Drug Prices?

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER